Anti‐PrP monoclonal antibody as a novel treatment for neurogenesis in mouse model of Alzheimer's disease
Abstract Background Alzheimer's disease (AD) is the most common degenerative disease characterized by cognitive impairment, memory decline, and language disorder for which there is no effective treatment. Neurogenesis has been indicated in AD and may play an important role in the pathogenesis o...
Enregistré dans:
Auteurs principaux: | Ruolin Li, Ming Ren, Yingxin Yu |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Wiley
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/cafe6ace1a4b4e5aa1e0069eb8f1fa22 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Agregados amiloides: rol en desórdenes de conformación proteica
par: Duran-Aniotz,Claudia, et autres
Publié: (2013) -
Ethanolamine Is a New Anti-Prion Compound
par: Keiji Uchiyama, et autres
Publié: (2021) -
Gamma Radiation-induced Impairment of Hippocampal Neurogenesis,Comparison of Single and Fractionated Dose Regimens
par: Khoshbin khoshnazar,A. R, et autres
Publié: (2012) -
Prion Infectivity and PrP<sup>BSE</sup> in the Peripheral and Central Nervous System of Cattle 8 Months Post Oral BSE Challenge
par: Ivett Ackermann, et autres
Publié: (2021) -
Attenuative Effects of Fluoxetine and <i>Triticum aestivum</i> against Aluminum-Induced Alzheimer’s Disease in Rats: The Possible Consequences on Hepatotoxicity and Nephrotoxicity
par: Karema Abu-Elfotuh, et autres
Publié: (2021)